In contrast, IGF2BP1 expression data for pancreatic adenocarcinomas, the most frequent pancreatic tumor-type, are available indicating that IGF2BP1 expression is overall upregulated in PDAC and associated with a significantly reduced overall survival (Figure 1A). This evidence concerns the gene IGF2BP1 and pancreatic adenocarcinoma.